
    
      This is an double-blind, multiple-dose, full replicate design, pharmacokinetic study of
      lamotrigine in "enriched" patients with epilepsy who previously participated in HP-00048923.
      LAMICTAL 100mg tablets and the most commonly used generic lamotrigine 100mg tablet (from
      Teva) will be compared pharmacokinetically.
    
  